Cover Image
Market Research Report
Product code 
1055043

Global Biosensors Market 2022-2026

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Biosensors Market 2022-2026
Published: November 29, 2021
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

Technavio has been monitoring the biosensors market and it is poised to grow by $ 10.85 bn during 2022-2026, progressing at a CAGR of 7.70% during the forecast period. Our report on the biosensors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the advances in biosensor technology and the advantages of biosensors in drug analysis. In addition, advances in biosensor technology is anticipated to boost the growth of the market as well.

The biosensors market analysis includes the product segment and geographic landscape.

Technavio's biosensors market is segmented as below:

By Product

  • Wearable
  • Non-wearable

By Geographical Landscape

  • North America
  • Europe
  • APAC
  • South America
  • MEA

This study identifies the wearable biosensors for wellness monitoringas one of the prime reasons driving the biosensors market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on biosensors market covers the following areas:

  • Biosensors market sizing
  • Biosensors market forecast
  • Biosensors market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biosensors market vendors that include Abbott Laboratories, Bio Rad Laboratories Inc., Biosensors International Group Ltd., Cytiva, Dexcom Inc., DuPont de Nemours Inc., LifeScan IP Holdings LLC, Masimo Corp., Medtronic Plc, and Universal Biosensors Group. Also, the biosensors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR71617

Table of Contents

  • Executive Summary
    • Market Overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2021
    • Market outlook: Forecast for 2021 - 2026
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Product
    • Market segments
    • Comparison by Product
    • Wearable - Market size and forecast 2021-2026
    • Non-wearable - Market size and forecast 2021-2026
    • Market opportunity by Product
  • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2021-2026
    • Europe - Market size and forecast 2021-2026
    • APAC - Market size and forecast 2021-2026
    • South America - Market size and forecast 2021-2026
    • MEA - Market size and forecast 2021-2026
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Vendor landscape
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Abbott Laboratories
    • Bio Rad Laboratories Inc.
    • Biosensors International Group Ltd.
    • Cytiva
    • Dexcom Inc.
    • DuPont de Nemours Inc.
    • LifeScan IP Holdings LLC
    • Masimo Corp.
    • Medtronic Plc
    • Universal Biosensors Group
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2021 - 2026 ($ million)
  • 13: Global market: Year-over-year growth 2021 - 2026 (%)
  • 14: Five forces analysis 2021 & 2026
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2021
  • 21: Product - Market share 2021-2026 (%)
  • 22: Comparison by Product
  • 23: Wearable - Market size and forecast 2021-2026 ($ million)
  • 24: Wearable - Year-over-year growth 2021-2026 (%)
  • 25: Non-wearable - Market size and forecast 2021-2026 ($ million)
  • 26: Non-wearable - Year-over-year growth 2021-2026 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share By Geographical Landscape 2021-2026 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2021-2026 ($ million)
  • 32: North America - Year-over-year growth 2021-2026 (%)
  • 33: Europe - Market size and forecast 2021-2026 ($ million)
  • 34: Europe - Year-over-year growth 2021-2026 (%)
  • 35: APAC - Market size and forecast 2021-2026 ($ million)
  • 36: APAC - Year-over-year growth 2021-2026 (%)
  • 37: South America - Market size and forecast 2021-2026 ($ million)
  • 38: South America - Year-over-year growth 2021-2026 (%)
  • 39: MEA - Market size and forecast 2021-2026 ($ million)
  • 40: MEA - Year-over-year growth 2021-2026 (%)
  • 41: Key leading countries
  • 42: Market opportunity By Geographical Landscape ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: Abbott Laboratories - Overview
  • 50: Abbott Laboratories - Business segments
  • 51: Abbott Laboratories - Key offerings
  • 52: Abbott Laboratories - Key customers
  • 53: Abbott Laboratories - Segment focus
  • 54: Bio Rad Laboratories Inc. - Overview
  • 55: Bio Rad Laboratories Inc. - Business segments
  • 56: Bio Rad Laboratories Inc. - Key offerings
  • 57: Bio Rad Laboratories Inc. - Key customers
  • 58: Bio Rad Laboratories Inc. - Segment focus
  • 59: Biosensors International Group Ltd. - Overview
  • 60: Biosensors International Group Ltd. - Product and service
  • 61: Biosensors International Group Ltd. - Key offerings
  • 62: Biosensors International Group Ltd. - Key customers
  • 63: Biosensors International Group Ltd. - Segment focus
  • 64: Cytiva - Overview
  • 65: Cytiva - Product and service
  • 66: Cytiva - Key offerings
  • 67: Cytiva - Key customers
  • 68: Cytiva - Segment focus
  • 69: Dexcom Inc. - Overview
  • 70: Dexcom Inc. - Business segments
  • 71: Dexcom Inc. - Key offerings
  • 72: Dexcom Inc. - Key customers
  • 73: Dexcom Inc. - Segment focus
  • 74: DuPont de Nemours Inc. - Overview
  • 75: DuPont de Nemours Inc. - Business segments
  • 76: DuPont de Nemours Inc. - Key offerings
  • 77: DuPont de Nemours Inc. - Key customers
  • 78: DuPont de Nemours Inc. - Segment focus
  • 79: LifeScan IP Holdings LLC - Overview
  • 80: LifeScan IP Holdings LLC - Product and service
  • 81: LifeScan IP Holdings LLC - Key offerings
  • 82: LifeScan IP Holdings LLC - Key customers
  • 83: LifeScan IP Holdings LLC - Segment focus
  • 84: Masimo Corp. - Overview
  • 85: Masimo Corp. - Business segments
  • 86: Masimo Corp. - Key offerings
  • 87: Masimo Corp. - Key customers
  • 88: Masimo Corp. - Segment focus
  • 89: Medtronic Plc - Overview
  • 90: Medtronic Plc - Business segments
  • 91: Medtronic Plc - Key offerings
  • 92: Medtronic Plc - Key customers
  • 93: Medtronic Plc - Segment focus
  • 94: Universal Biosensors Group - Overview
  • 95: Universal Biosensors Group - Business segments
  • 96: Universal Biosensors Group - Key offerings
  • 97: Universal Biosensors Group - Key customers
  • 98: Universal Biosensors Group - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations